OBJECTIVE: Intraventricular hemorrhage is associated with a very poor outcome. Simple external ventricular drainage alone has not resulted in a decline of mortality. The aim was to study the effect of direct intraventricular administration of recombinant tissue plasminogen activator (rtPA). PATIENTS AND METHODS: A retrospective series of eighteen adult patients with severe intraventricular hemorrhage, admitted to our university hospital, was studied for the effect of direct intraventricular administration of recombinant tissue plasminogen activator (rtPA). rtPA was administered in a dosage of 2mg. The injection was repeated at 12h intervals until serial CT scans showed a substantial reduction of intraventricular blood. RESULTS: The total of rtPA doses per patient ranged from 2 to 32mg. Seven out of 18 patients showed good neurological recovery, 4 died. Only one patient had a complication which could be directly attributed to the intraventricular thrombolytic therapy. CONCLUSION: We conclude that the procedure of intraventricular administration of a thrombolytic agent, i.e. rtPA, seems effective in lysis of the intraventricular hematoma and may, therefore, improve outcome.
OBJECTIVE:Intraventricular hemorrhage is associated with a very poor outcome. Simple external ventricular drainage alone has not resulted in a decline of mortality. The aim was to study the effect of direct intraventricular administration of recombinant tissue plasminogen activator (rtPA). PATIENTS AND METHODS: A retrospective series of eighteen adult patients with severe intraventricular hemorrhage, admitted to our university hospital, was studied for the effect of direct intraventricular administration of recombinant tissue plasminogen activator (rtPA). rtPA was administered in a dosage of 2mg. The injection was repeated at 12h intervals until serial CT scans showed a substantial reduction of intraventricular blood. RESULTS: The total of rtPA doses per patient ranged from 2 to 32mg. Seven out of 18 patients showed good neurological recovery, 4 died. Only one patient had a complication which could be directly attributed to the intraventricular thrombolytic therapy. CONCLUSION: We conclude that the procedure of intraventricular administration of a thrombolytic agent, i.e. rtPA, seems effective in lysis of the intraventricular hematoma and may, therefore, improve outcome.
Authors: David Rubin; Alejandro Santillan; Jeffrey P Greenfield; Mark Souweidane; Howard A Riina Journal: Childs Nerv Syst Date: 2010-07-02 Impact factor: 1.475
Authors: Alastair J S Webb; Natalie L Ullman; Sarah Mann; John Muschelli; Issam A Awad; Daniel F Hanley Journal: Stroke Date: 2012-04-03 Impact factor: 7.914
Authors: Holly E Hinson; Eric Melnychuk; John Muschelli; Daniel F Hanley; Issam A Awad; Wendy C Ziai Journal: Neurocrit Care Date: 2012-06 Impact factor: 3.210
Authors: Daniel A Jackson; Alden V Patel; Robert M Darracott; Ricardo A Hanel; William D Freeman; Daniel F Hanley Journal: Neurocrit Care Date: 2013-08 Impact factor: 3.210
Authors: Wendy Ziai; Tom Moullaali; Saman Nekoovaght-Tak; Natalie Ullman; Jay S Brooks; Timothy C Morgan; Daniel F Hanley Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210